[go: up one dir, main page]

ZA93531B - Biphenyl-substituted quinoline derivatives. - Google Patents

Biphenyl-substituted quinoline derivatives.

Info

Publication number
ZA93531B
ZA93531B ZA93531A ZA93531A ZA93531B ZA 93531 B ZA93531 B ZA 93531B ZA 93531 A ZA93531 A ZA 93531A ZA 93531 A ZA93531 A ZA 93531A ZA 93531 B ZA93531 B ZA 93531B
Authority
ZA
South Africa
Prior art keywords
biphenyl
quinoline derivatives
substituted quinoline
substituted
derivatives
Prior art date
Application number
ZA93531A
Other languages
English (en)
Inventor
Denis Evan Ryono
John Lloyd
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA93531B publication Critical patent/ZA93531B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA93531A 1992-02-14 1993-01-25 Biphenyl-substituted quinoline derivatives. ZA93531B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83778292A 1992-02-14 1992-02-14

Publications (1)

Publication Number Publication Date
ZA93531B true ZA93531B (en) 1993-08-26

Family

ID=25275409

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93531A ZA93531B (en) 1992-02-14 1993-01-25 Biphenyl-substituted quinoline derivatives.

Country Status (16)

Country Link
EP (1) EP0556060A1 (xx)
JP (1) JPH05286939A (xx)
KR (1) KR930017891A (xx)
CN (1) CN1044243C (xx)
AU (1) AU656454B2 (xx)
CA (1) CA2089185A1 (xx)
FI (1) FI930621A (xx)
HU (1) HU217627B (xx)
IL (1) IL104623A (xx)
MX (1) MX9300742A (xx)
NO (1) NO930520L (xx)
NZ (1) NZ245757A (xx)
PL (1) PL172241B1 (xx)
RU (1) RU2122540C1 (xx)
TW (1) TW297025B (xx)
ZA (1) ZA93531B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767129A (en) * 1995-08-24 1998-06-16 Warner-Lambert Company Substituted quinolines and isoquinolines as calcium channel blockers, their preparation and the use thereof
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
AU2002241966A1 (en) 2001-01-26 2002-08-28 Chugai Seiyaku Kabushiki Kaisha Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
EP1353662B1 (en) 2001-01-26 2007-04-18 Chugai Seiyaku Kabushiki Kaisha Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
AU2002245294B2 (en) 2001-01-26 2005-09-22 Chugai Seiyaku Kabushiki Kaisha Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
NZ526883A (en) 2001-02-20 2005-11-25 Chugai Pharmaceutical Co Ltd Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
ES2295930T3 (es) 2003-08-01 2008-04-16 Chugai Seiyaku Kabushiki Kaisha Compuestos de cianoamida utiles como inhibidores de malonil-coa descarboxilasa.
DE602004014937D1 (de) 2003-08-01 2008-08-21 Chugai Pharmaceutical Co Ltd Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer
DE602004016530D1 (de) 2003-08-01 2008-10-23 Chugai Pharmaceutical Co Ltd Azol-verbindungen auf cyanoguanidin-basis als malonyl-coa decarboxylase-hemmer
DE602004030017D1 (de) 2003-08-01 2010-12-23 Chugai Pharmaceutical Co Ltd Heterocyclische verbindungen als nützliche malonyl-coa decarboxylase-hemmer
GB0519969D0 (en) * 2005-09-30 2005-11-09 Argenta Discovery Ltd Quinoline compounds
AU2006296397B2 (en) 2005-09-30 2011-12-15 Gb001, Inc. Quinolines and their therapeutic use
US8173812B2 (en) * 2007-04-04 2012-05-08 Pulmagen Therapeutics (Asthma) Limited Quinolines and their therapeutic use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903911A1 (en) * 1989-11-20 1991-05-22 Ici Plc Diazine derivatives
GB9102727D0 (en) * 1991-02-08 1991-03-27 Ici Plc Pharmaceutical agent
US5157040A (en) * 1991-04-05 1992-10-20 Merck & Co., Inc. Substituted quinolines as angiotensin ii antagonists

Also Published As

Publication number Publication date
PL297713A1 (en) 1993-08-23
KR930017891A (ko) 1993-09-20
TW297025B (xx) 1997-02-01
IL104623A0 (en) 1993-06-10
NO930520L (no) 1993-08-16
IL104623A (en) 1996-12-05
MX9300742A (es) 1993-09-01
HUT69694A (en) 1995-09-28
CA2089185A1 (en) 1993-08-15
PL172241B1 (pl) 1997-08-29
JPH05286939A (ja) 1993-11-02
RU2122540C1 (ru) 1998-11-27
FI930621A (fi) 1993-08-15
HU217627B (hu) 2000-03-28
AU3299193A (en) 1993-08-19
NO930520D0 (no) 1993-02-12
NZ245757A (en) 1995-09-26
AU656454B2 (en) 1995-02-02
CN1075720A (zh) 1993-09-01
EP0556060A1 (en) 1993-08-18
CN1044243C (zh) 1999-07-21
FI930621A0 (fi) 1993-02-12
HU9300386D0 (en) 1993-04-28

Similar Documents

Publication Publication Date Title
ZA934603B (en) thiazolylvinylphenyl derivatives.
GB9108547D0 (en) Quinoline derivatives
PL307812A1 (en) Substituted thiazolydinone derivatives
HU9300545D0 (en) Sulfobenzyil-substituted pyridone derivatives
GB9305306D0 (en) Pyrrolo-pyridazione derivatives
HU9301955D0 (en) Benzophenone-hydrazone derivatives
EP0572808A3 (de) Antiblockierregelsystem.
ZA93531B (en) Biphenyl-substituted quinoline derivatives.
ZA969812B (en) Novel quinoline derivatives.
EP0668864A4 (en) SUBSTITUTED BIPHENYLMETHYLIMIDAZOPYRIDINES.
ZA931876B (en) 2-Oxoquinoline derivatives
IL101627A0 (en) 4-aryl-3-(heteroarylureido)quinoline derivatives
ZA932639B (en) Propenoyl-imidazole derivatives
GB2270913B (en) Chlordifluoromethoxyphenyl derivatives
GB2271564B (en) Thioalkylthio carbacephalosporin derivatives
GB9126438D0 (en) New quinoline derivatives
ZA931516B (en) Substituted phenylquinazoline derivatives
ZA935478B (en) Lactam derivatives.
GR3033237T3 (en) Quinoline derivatives as leukoriene antagonists.
EP0565961A3 (en) Ethyl-triazolyl derivatives
ZA931109B (en) Tetrahydropyrimidine derivatives.
ZA936048B (en) Novel 3-oxadiazolyl-1,6-napthyridine derivatives
GB9223244D0 (en) Phenylpyrazine derivatives
HU9302058D0 (en) Thia-diazinone derivatives
ZA934972B (en) 21-Chloro-pregnane derivative